This study identified six serum miRNAs that distinguish AD patients from healthy controls with high sensitivity and specificity.Serum miRNA panel(or miR-342-3p alone)may serve as a novel,noninvasive biomarker for AD.
NSDNA: The Nervous System Disease NcRNAome Atlas
Contact wanglh211@163.com for inquiries and feedback